Larvicide Market Size and Outlook 2031

Report Description

Forecast Period	2027-2031
Market Size (2025)	USD 905.84 Million
CAGR (2026-2031)	5.64%
Fastest Growing Segment	Bio control Agents
Largest Market	North America
Market Size (2031)	USD 1258.99 Million

Market Overview

The Global Larvicide Market will grow from USD 905.84 Million in 2025 to USD 1258.99 Million by 2031 at a 5.64% CAGR. Larvicides are specialized chemical or biological agents applied to aquatic breeding habitats to eliminate insect larvae before they mature into disease-transmitting adults. The market is primarily driven by the escalating global burden of vector-borne diseases and rapid urbanization, which creates expansive breeding grounds requiring consistent management. Furthermore, the increasing adoption of Integrated Pest Management strategies by municipal authorities fosters strong demand for these preventative solutions over reactive adulticide methods. According to the Pan American Health Organization, in 2024, the Americas region recorded over 13 million dengue cases, a figure that underscores the urgent and expanding necessity for effective larval control interventions to mitigate public health risks.

Despite these robust growth drivers, one significant challenge impeding market expansion is the stringent regulatory environment regarding environmental toxicity and safety. Manufacturers must navigate complex compliance frameworks and rigorous impact studies, which substantially prolong product development cycles and elevate entry costs. This regulatory bottleneck compels the industry to dedicate extensive resources to approval processes, effectively slowing the commercialization of novel active ingredients required to address emerging resistance in target vector populations.

Key Market Drivers

Climate change-driven expansion of vector breeding zones is fundamentally altering the geographic landscape of the global larvicide market. As rising temperatures extend warm seasons in temperate regions, mosquitoes are establishing populations in previously unaffected latitudes, necessitating new larval management programs. This geographical shift forces municipal bodies to implement vector control in areas that historically required no intervention, thereby creating new regional markets for abatement products. According to the European Centre for Disease Prevention and Control, June 2024, in the 'Annual Epidemiological Report', there were 130 locally acquired cases of dengue reported in the EU/EEA in 2023, a significant increase compared to 71 cases in the previous year, signaling the urgent need for preventative larvicide application in these emerging territories.

Escalating government investment in public health vector control concurrently propels market growth as nations mobilize financial resources to combat these outbreaks. Federal agencies are allocating substantial emergency funds to procure biological and chemical larvicides, particularly during peak transmission seasons, to suppress vector populations effectively. According to the Government of Brazil, February 2024, in the 'Ministry of Health Expands Resources for Dengue Emergencies' announcement, the federal government increased the funds reserved for dengue emergencies to R$ 1.5 billion to support states and municipalities. This financial commitment underpins the procurement of control agents. Furthermore, the broader funding landscape remains robust; according to the World Health Organization, in 2023, total funding mobilized for malaria control and elimination globally reached US$ 4.1 billion, sustaining the demand for integrated vector management solutions.

Download Free Sample Report

Key Market Challenges

The stringent regulatory environment regarding environmental toxicity and safety acts as a substantial restraint on the Global Larvicide Market. To ensure products do not disrupt aquatic ecosystems, manufacturers must adhere to complex compliance frameworks and fund extensive toxicological impact studies. This rigorous scrutiny necessitates significant capital investment and extends the research and development phase, effectively creating high barriers to entry that deter smaller enterprises and consolidate market share among a few large incumbents.

These regulatory bottlenecks directly delay the commercialization of novel active ingredients needed to combat resistance in vector populations. According to CropLife International, in 2024, the average cost to discover, develop, and register a new crop protection product surpassed $300 million, with the entire process taking an average of 12.3 years to complete. Such prolonged timelines limit the industry's ability to swiftly introduce new formulations. Consequently, the market experiences a stagnation in product innovation, reducing the availability of diverse chemical rotation options required for sustainable long-term vector management.

Key Market Trends

The Integration of AI and GIS for Precision Larviciding is revolutionizing vector control by replacing blanket spraying with data-driven interventions. These technologies utilize predictive analytics to map breeding hotspots, allowing municipal authorities to optimize resource allocation and target interventions with high accuracy, thereby minimizing environmental impact. For instance, the transition to smart surveillance enables real-time monitoring of vector density, automating response protocols for targeted treatment in critical urban zones. According to The Indian Express, July 2025, in the 'In Andhra Pradesh, tackling mosquito menace – with a little help from AI' article, the state government launched the Smart Mosquito Surveillance System (SMoSS) across 66 locations to monitor mosquito populations and guide precise larvicide application.

Deployment of Drone Technology for Aerial Application is concurrently transforming the market by enabling access to hard-to-reach aquatic habitats that are difficult to treat manually. Unmanned aerial vehicles (UAVs) equipped with specialized dispensers offer superior efficiency, particularly in treating expansive marshlands or complex water bodies where traditional ground crews struggle with coverage. This automation significantly enhances the speed of deployment during peak breeding seasons while reducing the physical burden on field workers. According to The Guardian Nigeria News, November 2025, in the 'Firm to introduce drone, AI-driven mosquito-control system' article, SORA Technology's new drone-based solution demonstrated the ability to reduce larvicide usage and labor costs by up to 70% compared to traditional manual methods.

Segmental Insights

The Biocontrol Agents segment is identified as the fastest-growing category in the Global Larvicide Market due to increasing regulatory restrictions on synthetic chemicals. This growth is largely driven by the World Health Organization recommending biological interventions to counter the rising resistance of vectors to conventional chemical treatments. Furthermore, stringent guidelines from the U.S. Environmental Protection Agency regarding environmental toxicity have accelerated the shift toward safer bacterial formulations. These factors are compelling public health authorities to adopt sustainable biological agents, ensuring effective mosquito population management while complying with rigorous ecological safety standards.

Regional Insights

North America currently maintains a dominant position in the global larvicide market, driven by rising concerns regarding vector-borne diseases such as West Nile virus. This regional leadership is supported by favorable government initiatives and a well-structured regulatory framework managed by the United States Environmental Protection Agency. Additionally, the region demonstrates high adoption rates of control agents within Integrated Vector Management programs implemented by local municipalities to ensure public safety. These coordinated efforts to maintain public health and established pest control infrastructure ensure North America remains the primary revenue contributor.

Recent Developments

In October 2025, Valent BioSciences LLC, MGK, and Valent North America LLC announced their consolidation into a single unified organization known as Sumitomo Biorational Company LLC. This major reorganization merged the U.S.-based biorational and sustainable agriculture subsidiaries of Sumitomo Chemical to form a global center of excellence for innovation. The integration was designed to combine the research, development, and commercial strengths of the entities, which are market leaders in biological larvicides and vector control products. The new company aimed to streamline operations and enhance the delivery of effective, sustainable pest management solutions to public health and agricultural markets worldwide.
In September 2025, the World Mosquito Program and Debug, a project by Alphabet’s Verily, announced a collaboration to accelerate the fight against mosquito-borne diseases. The partnership integrated the World Mosquito Program’s Wolbachia method, which reduces the ability of mosquitoes to transmit viruses, with Debug’s proprietary automated rearing and release technologies. By combining these capabilities, the organizations aimed to rapidly scale the deployment of Wolbachia-treated mosquitoes to suppress disease transmission more efficiently. This cooperation marked a significant advancement in the use of technology-driven biological solutions to control vectors responsible for dengue, Zika, and chikungunya.
In December 2024, Oxitec Ltd partnered with CSIRO, the national science agency of Australia, to launch a new venture named Oxitec Australia. This collaboration was established to introduce Oxitec’s biological pest control solutions to the region, specifically targeting invasive mosquito species such as Aedes aegypti and Aedes albopictus. The initiative aimed to deploy Oxitec’s self-limiting mosquito technology, which suppresses local pest populations without relying on chemical pesticides. The joint venture focused on combining Oxitec’s proven platform with CSIRO’s scientific expertise to address the growing threat of diseases like dengue and Zika across the Indo-Pacific.
In October 2024, Envu announced that it had signed a definitive agreement to acquire In2Care, a technology company specializing in novel mosquito control products. This strategic acquisition allowed Envu to expand its mosquito management portfolio by integrating In2Care’s patented technology, which utilizes a static-charged coating on netting to bind biocide powders. The innovation enables mosquitoes to transfer lethal doses of larvicide to their breeding sites, effectively killing larvae and reducing disease transmission. The move reinforced Envu's commitment to delivering nature-positive solutions and enhanced its ability to support public health professionals in controlling vector-borne diseases.

Key Market Players

BASF SE
Bayer AG
Syngenta
ADAMA Agricultural Solutions Limited
Sumitomo Chemical Co., Ltd
Certis USA L.L.C.
Summit Chemical Specialty Products, LLC
Central Garden & Pet Company.
Nufarm Ltd
Russell IPM Ltd

By Form	By Control Method	By End Use Sector	By Region
Solid and Liquid	Bio control Agents Chemical Agents Insect Growth Regulators and Other Control Methods	Public Health Agricultural Commercial Residential and Livestock	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Larvicide Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Larvicide Market, By Form:

Solid and Liquid

Larvicide Market, By Control Method:

Bio control Agents
Chemical Agents
Insect Growth Regulators and Other Control Methods

Larvicide Market, By End Use Sector:

Public Health
Agricultural
Commercial
Residential and Livestock

Larvicide Market, By Region:

North America

United States
Canada
Mexico

Europe

France
United Kingdom
Italy
Germany
Spain

Asia Pacific

China
India
Japan
Australia
South Korea

South America

Brazil
Argentina
Colombia

Middle East & Africa

South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Larvicide Market.

Available Customizations:

Global Larvicide Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Larvicide Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Larvicide Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Form (Solid and Liquid)

5.2.2. By Control Method (Bio control Agents, Chemical Agents, Insect Growth Regulators and Other Control Methods)

5.2.3. By End Use Sector (Public Health, Agricultural, Commercial, Residential and Livestock)

5.2.4. By Region

5.2.5. By Company (2025)

5.3. Market Map

6. North America Larvicide Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Form

6.2.2. By Control Method

6.2.3. By End Use Sector

6.2.4. By Country

6.3. North America: Country Analysis

6.3.1. United States Larvicide Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Form

6.3.1.2.2. By Control Method

6.3.1.2.3. By End Use Sector

6.3.2. Canada Larvicide Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Form

6.3.2.2.2. By Control Method

6.3.2.2.3. By End Use Sector

6.3.3. Mexico Larvicide Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Form

6.3.3.2.2. By Control Method

6.3.3.2.3. By End Use Sector

7. Europe Larvicide Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Form

7.2.2. By Control Method

7.2.3. By End Use Sector

7.2.4. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Larvicide Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Form

7.3.1.2.2. By Control Method

7.3.1.2.3. By End Use Sector

7.3.2. France Larvicide Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Form

7.3.2.2.2. By Control Method

7.3.2.2.3. By End Use Sector

7.3.3. United Kingdom Larvicide Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Form

7.3.3.2.2. By Control Method

7.3.3.2.3. By End Use Sector

7.3.4. Italy Larvicide Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Form

7.3.4.2.2. By Control Method

7.3.4.2.3. By End Use Sector

7.3.5. Spain Larvicide Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Form

7.3.5.2.2. By Control Method

7.3.5.2.3. By End Use Sector

8. Asia Pacific Larvicide Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Form

8.2.2. By Control Method

8.2.3. By End Use Sector

8.2.4. By Country

8.3. Asia Pacific: Country Analysis

8.3.1. China Larvicide Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Form

8.3.1.2.2. By Control Method

8.3.1.2.3. By End Use Sector

8.3.2. India Larvicide Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Form

8.3.2.2.2. By Control Method

8.3.2.2.3. By End Use Sector

8.3.3. Japan Larvicide Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Form

8.3.3.2.2. By Control Method

8.3.3.2.3. By End Use Sector

8.3.4. South Korea Larvicide Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Form

8.3.4.2.2. By Control Method

8.3.4.2.3. By End Use Sector

8.3.5. Australia Larvicide Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Form

8.3.5.2.2. By Control Method

8.3.5.2.3. By End Use Sector

9. Middle East & Africa Larvicide Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Form

9.2.2. By Control Method

9.2.3. By End Use Sector

9.2.4. By Country

9.3. Middle East & Africa: Country Analysis

9.3.1. Saudi Arabia Larvicide Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Form

9.3.1.2.2. By Control Method

9.3.1.2.3. By End Use Sector

9.3.2. UAE Larvicide Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Form

9.3.2.2.2. By Control Method

9.3.2.2.3. By End Use Sector

9.3.3. South Africa Larvicide Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Form

9.3.3.2.2. By Control Method

9.3.3.2.3. By End Use Sector

10. South America Larvicide Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Form

10.2.2. By Control Method

10.2.3. By End Use Sector

10.2.4. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Larvicide Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Form

10.3.1.2.2. By Control Method

10.3.1.2.3. By End Use Sector

10.3.2. Colombia Larvicide Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Form

10.3.2.2.2. By Control Method

10.3.2.2.3. By End Use Sector

10.3.3. Argentina Larvicide Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Form

10.3.3.2.2. By Control Method

10.3.3.2.3. By End Use Sector

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)

12.2. Product Launches (If Any)

12.3. Recent Developments

13. Global Larvicide Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. BASF SE

15.1.1. Business Overview

15.1.2. Products & Services

15.1.3. Recent Developments

15.1.4. Key Personnel

15.1.5. SWOT Analysis

15.2. Bayer AG

15.3. Syngenta

15.4. ADAMA Agricultural Solutions Limited

15.5. Sumitomo Chemical Co., Ltd

15.6. Certis USA L.L.C.

15.7. Summit Chemical Specialty Products, LLC

15.8. Central Garden & Pet Company.

15.9. Nufarm Ltd

15.10. Russell IPM Ltd

16. Strategic Recommendations

17. About Us & Disclaimer

Report Description

Table of content

Figures and Tables

Frequently asked questions

What was the market size of the Global Larvicide Market in 2025?

Which is the dominating region in the Global Larvicide Market?

Which is the fastest growing segment in the Global Larvicide Market?

What is the expected growth rate of the Global Larvicide Market?